Clinical and genetic epidemiology of Parkinson's disease: focus on disease progression and non-motor symptoms.
Clinical and genetic epidemiology of Parkinson's disease: focus on disease progression and non-motor symptoms.
Dissecting the link between astrocyte diversity and PD risk” to investigate how neurodegenerative diseases, including Parkinson’s disease, intersect with regional aspects of astrocyte identity
Longitudinal measurement of synaptic density to monitor progression of Parkinson's disease and Huntington's disease
Prospective head-to-head comparison of cardiac [18F]-MFBG PET versus [123I]-MIBG SPECT in the differentiation between Parkinson’s disease and multiple system atrophy and between dementia with Lewy bodies and Alzheimer’s disease.
Gastrointestinal syndromes preceding a diagnosis of Parkinson's disease: testing Braak's hypothesis using a nationwide database for comparison with Alzheimer's disease and cerebrovascular diseases
Risk of valvular heart disease associated with the use of dopamine agonists in Parkinson's disease: a systematic review
Big data in Parkinson's disease: using smartphones to remotely detect longitudinal disease phenotypes
Crystal structure of the 5-phosphatase domain of Synaptojanin1 bound to its substrate diC8-PI(3,4,5)P3 in complex with a nanobody.